In our latest episode of Lexicon, we sat down with Annette Höglund-Dönnes, Chief Commercial Officer at Polar Night Energy, to explore how the company’s sand battery is helping municipalities and ...

Minecraft Chaos Cubed update is live today as Java Edition 26.2 and Bedrock Edition 26.30. The release adds Sulfur Caves, a block-absorbing mob with eight physics archetypes, a native Java friends ...

It is the most extracted solid material on Earth – but this extraction can threaten ecosystems and livelihoods Malé is one of the world’s most overcrowded cities, but it faces double pressure. As well ...

GENEVA, May 12 (Reuters) - Growing global demand for sand, driven by rapid urbanisation and construction, is exceeding sustainable supply and putting ecosystems and livelihoods at risk, ‌the United ...

If you've ever wanted to integrate OpenAI's ChatGPT features into your Java programs, you'll be happy to learn that Spring AI has made the process easier than ever. And it's not just easier to connect ...

SAND SPRINGS — After Beale Infrastructure recently canceled Coweta’s data center project, KRMG spoke to Sand Springs City Manager Mike Carter about how the data center in Sand Springs was progressing.

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Pills, tablets and capsules on world map with charts blue background. International ...

Despite wide availability of biologic drugs for asthma, use of these injectable medicines remains low — patients just dislike frequent injections. Generate Biomedicine’s lead drug candidate could ...

Generate:Biomedicines has earmarked $300 million of its IPO funds to complete a pair of phase 3 asthma trials for its anti-TSLP antibody GB-0895. (Fabrice Cabaud/Stock/Getty Images Plus) ...

Generate Biomedicines Inc. raised $400 million in an initial public offering, pricing its shares at the midpoint of the marketed range. The Somerville, Massachusetts-based drug developer sold 25 ...

Feb 26 (Reuters) - Generate Biomedicines said on Thursday that it raised $400 million in its U.S. initial public offering, pricing shares of the U.S.-based drug developer at $16 each. The offering ...

Generate Biomedicines Inc., a biotechnology firm using artificial intelligence in drug development, is seeking to raise as much as $425 millon in an initial public offering, as listing activity in the ...